COMMUNIQUÉS West-GlobeNewswire

First Steroid Cycle: Best Steroids for Muscle Growth (Before And After Result), Steroids for Beginners - By CrazyBulk USA
16/05/2025
New York City, NY, May 16, 2025 (GLOBE NEWSWIRE) -- Initiating the first steroid cycle as a new bodybuilder may be thrilling yet terrifying. Despite all the information and diverse counsel obtainable over the internet, [...]
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)
16/05/2025
RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO ® (berotralstat) in [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/05/2025
WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]
Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick
16/05/2025
Arialief’s 7-Second Nerve Relief Trick Sparks a Holistic Neuropathy Craze—Science-Backed Formula Calms Inflammation and Restores Nerve Comfort with Each Daily Dose AURORA, Colo., May 16, 2025 (GLOBE NEWSWIRE) -- What [...]
Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews
16/05/2025
Bruno Male Enhancement has summarized all the health benefits altogether. With the essence of natural ingredients, men have lost their manhood. This perfect blend of natural ingredients makes your overall health smooth [...]
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
16/05/2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
Merus annonce la publication d’un article sur le mécanisme d’action du pétosemtamab
16/05/2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 16 mai 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », « la Société », « nous » ou « notre/nos », une société d’oncologie au stade clinique [...]
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16/05/2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Best Testosterone Booster for Men – Why TestoPrime is the Top Choice for Libido, Performance, and Vitality
15/05/2025
Explore how TestoPrime naturally enhances testosterone to improve energy, improve libido, sexual health and support performance, offering a safe and effective alternative to conventional treatments for Erectile [...]
Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
15/05/2025
Bodybuilding support made simple. Find top SARMs for sale, ideal for cutting or bulking cycles, all with legal, safe alternatives in one guide by Crazybulk New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- [...]
Dianabol (Dbol) For Sale 2025: Best Legal Dbol Pills, Cycles & Stacking Guide
15/05/2025
Looking for Dianabol in 2025? Find legal Dbol pills, smart stacking advice, and trusted options for muscle and recovery support backed by Wolfson Brands (UK) Limited New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- [...]
Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update
15/05/2025
DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today [...]
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
15/05/2025
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States [...]
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
15/05/2025
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule [...]
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
15/05/2025
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected [...]
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
15/05/2025
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv [...]
SRx Health Solutions Announces First Quarter 2025 Financial Results
15/05/2025
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA 1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin 1 Improved (9)% , a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, [...]
Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
15/05/2025
– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical [...]
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
15/05/2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of- [...]

Pages